177 related articles for article (PubMed ID: 25533714)
1. Markers of endothelial function in migraine patients: Results from a bi-center prospective study.
Fischer M; Gaul C; Shanib H; Holle D; Loacker L; Griesmacher A; Lackner P; Broessner G
Cephalalgia; 2015 Sep; 35(10):877-85. PubMed ID: 25533714
[TBL] [Abstract][Full Text] [Related]
2. The Levels of Circulating Proangiogenic Factors in Migraineurs.
Michalak S; Kalinowska-Lyszczarz A; Wegrzyn D; Thielemann A; Osztynowicz K; Kozubski W
Neuromolecular Med; 2017 Dec; 19(4):510-517. PubMed ID: 28918499
[TBL] [Abstract][Full Text] [Related]
3. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure.
Eleuteri E; Di Stefano A; Tarro Genta F; Vicari C; Gnemmi I; Colombo M; Mezzani A; Giannuzzi P
Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):607-14. PubMed ID: 21450636
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor in primary headaches.
Fischer M; Wille G; Klien S; Shanib H; Holle D; Gaul C; Broessner G
J Headache Pain; 2012 Aug; 13(6):469-75. PubMed ID: 22584531
[TBL] [Abstract][Full Text] [Related]
5. Migraine and endothelial function: The HUNT3 Study.
Larsen JS; Skaug EA; Wisløff U; Ellingsen Ø; Stovner LJ; Linde M; Hagen K
Cephalalgia; 2016 Dec; 36(14):1341-1349. PubMed ID: 26868818
[TBL] [Abstract][Full Text] [Related]
6. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee KW; Lip GY; Blann AD
Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
[TBL] [Abstract][Full Text] [Related]
7. Circulating angiopoietins in idiopathic pulmonary arterial hypertension.
Kümpers P; Nickel N; Lukasz A; Golpon H; Westerkamp V; Olsson KM; Jonigk D; Maegel L; Bockmeyer CL; David S; Hoeper MM
Eur Heart J; 2010 Sep; 31(18):2291-300. PubMed ID: 20601390
[TBL] [Abstract][Full Text] [Related]
8. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
[TBL] [Abstract][Full Text] [Related]
9. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Alvarez R; Larrosa D; Ramón C; Pascual J
Cephalalgia; 2015 Apr; 35(4):310-6. PubMed ID: 24847167
[TBL] [Abstract][Full Text] [Related]
10. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
11. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
12. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
[TBL] [Abstract][Full Text] [Related]
13. Decreased number and function of endothelial progenitor cells in patients with migraine.
Lee ST; Chu K; Jung KH; Kim DH; Kim EH; Choe VN; Kim JH; Im WS; Kang L; Park JE; Park HJ; Park HK; Song EC; Lee SK; Kim M; Roh JK
Neurology; 2008 Apr; 70(17):1510-7. PubMed ID: 18354079
[TBL] [Abstract][Full Text] [Related]
14. Mmp-9 immunoreactivity in acute migraine.
Leira R; Sobrino T; Rodríguez-Yáñez M; Blanco M; Arias S; Castillo J
Headache; 2007 May; 47(5):698-702. PubMed ID: 17501851
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma transforming growth factor-beta1 in migraine.
Ishizaki K; Takeshima T; Fukuhara Y; Araki H; Nakaso K; Kusumi M; Nakashima K
Headache; 2005 Oct; 45(9):1224-8. PubMed ID: 16178953
[TBL] [Abstract][Full Text] [Related]
17. Platelet levels of dopamine are increased in migraine and cluster headache.
D'Andrea G; Granella F; Perini F; Farruggio A; Leone M; Bussone G
Headache; 2006 Apr; 46(4):585-91. PubMed ID: 16643552
[TBL] [Abstract][Full Text] [Related]
18. Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis.
Hamed SA; Hamed EA; Ezz Eldin AM; Mahmoud NM
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):92-103. PubMed ID: 20189084
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma matrix metalloproteinase-9 levels in migraineurs.
Imamura K; Takeshima T; Fusayasu E; Nakashima K
Headache; 2008 Jan; 48(1):135-9. PubMed ID: 18005141
[TBL] [Abstract][Full Text] [Related]
20. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
